NR546 / NR 546 Final Exam (Latest Update 2024 / 2025): Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Questions and Verified Answers - Chamberlain

Final Exam: NR546 / NR 546 Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Final Exam | Questions and Verified Answers | Latest Update 2024 / 2025 |Chamberlain Q: What antidepressant has the longest half life? Answer: fluoxetine Q: What antidepressant also treats social anxiety and insomnia Answer: paroxetine Q: What antidepressant treats anxious depression smokers require increased dose Answer: fluvoxamine Q: What antidepressant also treats social anxiety and hypersomnolence Answer: sertraline Q: This medication treats both depression and anxiety disorders, ensure trial of higher dose before switching to a different medication Answer: venlafaxine Q: This medication effective for perimenopausal vasomotor symptoms Answer: desvenlafaxine Q: This medication effective for atypical pain at higher doses; appropriate for clients who present with somatic symptoms of depression; effective for atypical pain, such as fibromyalgia and diabetic neuropathy Answer: duloxetine Q: This medication may improve energy, alertness, and motivation; not first line treatment for anxiety; contraindicated in clients with a history of seizures Answer: bupropion (Wellbutrin) - NDRI Q: This medication treats anxious depression smokers require increased dose Answer: fluvoxamine Q: This medication also treats social anxiety and hypersomnolence Answer: sertraline Q: This medication class potently block 5-HT2A and 5HT 2C receptors, which allow more 5-HT to interact at postsynaptic 5-HT1A sites. Serotonin blockade and reuptake inhibition is present at higher doses. Answer: Serotonin Antagonist and Reuptake Inhibitors (SARIs) Q: Is the most common SARI, also blocks histaminergic and α-adrenergic receptors. causes significant sedation, but has a short half-life; because of these features, low-dose may be used as adjunctive treatment for clients with major depression who report continued difficulty falling or staying asleep. Answer: Trazadone Q: were the first class of antidepressants developed. Today, they are the last choice medication class for depression due to the many potential, serious side effects. Answer: MAOIs Q: This Medication breaks down 5-HT, DA, NE, and tyramine and is used to treat depressions and anxiety. Answer: MAOIs Q: This type of MAOI is responsible for treating antidepressant or anxiolytic. Answer: MAO-A Q: Is responsible for the breakdown of dopamine, phenylethylamine, and tyramine. commonly used to treat Parkinson's disease. Answer: MAO-B